SLS 3D Ltd announced today partnership with Replica 3DM, at the launch of the All-Party Parliamentary Group on Personalised Medicine at Portcullis House on Tuesday, 13th March 2016. Replica 3DM medical models are “carbon copies” of the refined DICOM data from CT/MRI scans which allow surgeons to carry out pre-operative planning.

Researchers from UK and Spain used 3D Printing to help Visually Impaired using Printlets with Braille and Moon patterns. SLS 3D printing was used to fabricate the orally disintegrating printlets (ODPs) with Braille and Moon patterns, allowing patients to have fast knowledge regarding medication where Paracetamol was used as the model drug. The researchers believe this will encourages self-administration of medicines, improving patient compliance and treatment efficacy.

A Team of Researchers from UK experimented on using 3D Printing to create Orally disintegrating tablets (ODTs) of Ondansetron, a drug used in Vomiting receiving Chemotherapy, with the help of SLS 3D printing. The researchers developed a new type of ondansetron-cyclodextrin complexes meant to disintegrate rapidly, which were compared to Vonau Flash 8 mg, a commercial example of Ondansetron. Both 3D printed formulations disintegrated at ~15 s and released more than 90% of the drug within 5 min independent of the mannitol content, thus concluding that these results were comparable to those obtained with the commercial product with added benefit of using a manufacturing technology able to prepare medicines individualized to the patient.